Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present pivotal roxadustat Phase III data at the American Society of Nephrology Kidney Week 2019
-
AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia
-
Imfinzi and Imfinzi plus tremelimumab delayed disease progression in Phase III POSEIDON trial for 1st-line treatment of Stage IV non-small cell lung cancer
-
Year-to-date and Q3 2019 Results
-
AstraZeneca commits $35m to help young people tackle the threat of non-communicable diseases
-
Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes
-
Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer
-
Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen
-
AstraZeneca divests rights for Losec to Cheplapharm
-
Update on US regulatory review of PT010 in COPD
Latest articles and press releases
All of our latest press releases and articles are available to explore
